Gelonghui, May 8, 丨 Tianfu Energy (600509.SH) announced that Tianfu Biochemical was incorporated in September 2003, with a registered capital of 10 million yuan. Among them: The company holds 7.5 million yuan of shares, with a shareholding ratio of 75%; Shanghai Shengyao Biotechnology Co., Ltd. holds 2.5 million yuan of shares, with a shareholding ratio of 25%. Tianfu Biochemical's main business scope is the production and sale of pyruvic acid; since the project never reached production, its production line assets were transferred and sold in 2011; on March 31, 2024, Tianfu Biochemical's total assets were 252,000 yuan and net assets - 42.4082 million yuan. According to the reform requirements of state-owned state-owned enterprises, the company's management structure will be further optimized, management costs will be reduced, and operational efficiency will be improved. Tianfu Biochemical plans to be cancelled through bankruptcy and liquidation.
天富能源(600509.SH):控股子公司天富生化拟通过破产清算方式注销
Tianfu Energy (600509.SH): The holding subsidiary Tianfu Biochemical plans to be cancelled through bankruptcy and liquidation
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.